Introduction
Conjunctival microangiopathy are nonspecific, morphologic and hemodynamic changes associated with senility, degenerative vascular disease, rheumatic fever and sickle cell crisis and in normal adults after the third decade [1] .
They mainly involve the capillary and postcapillary venules of the conjunctival microvascular network, and alterations include increased capillary tortuosity, angularity, elongation and microaneurysm formation, as well as venular distention, tortuosity and focal dilation (saccular, fusiform or tricornuate). Arterioles demonstrated generalized narrowing with focal constrictions and loss of transparency [2] .
We describe a case where the severity of the conjunctival microangiopathy resulted in a painless unilateral red eye as the primary complaint, 5 years after successful control of underlying proliferative diabetic retinopathy and neovascular glaucoma (NVG). We are unaware of previous reports in the literature on conjunctival microangiopathy secondary to diabetes presenting as a red eye.
Case Report
A 52-year-old Tongan male presented with a unilateral painless red right eye, with 3 months of gradual onset. His past medical history included type II diabetes diagnosed 16 years ago, with poor systemic control, hypertension and hyperlipidemia.
His past ocular history included bilateral pseudophakia and bilateral panretinal photocoagulation for proliferative diabetic retinopathy 5 years prior to the current presentation. This was complicated by progression to NVG in the right eye after 2 months, with a presenting intraocular pressure (IOP) of 58 mm Hg. Gonioscopy revealed peripheral anterior synechiae involving three quadrants. IOP was stabilized with a superior temporally placed 230-mm 2 M3 Molteno implant, intravitreal bevacizumab and further panretinal photocoagulation. The patient remains off topical treatment.
On examination at the current presentation, his visual acuity was 6/9 OD and 6/12 OS, and IOP was 18 mm Hg OU. Slitlamp examination of the anterior segment of the right eye revealed venular dilation, beading, focal dilation (saccular, fusiform and tricornuate) and tortuosity. Capillaries demonstrated microaneurysm formation and tortuosity, with attenuated arterioles. The vascular changes involved the bulbar conjunctiva circumferentially, predominantly inferonasally. The changes were absent over both the bulbar conjunctiva of the bleb wall and the tarsal conjunctiva. The cornea showed inferior nasal early arborescent neovascularization with a pseudopterygium 1.2 mm from the temporal limbus ( fig. 1 ).
The pupil was oval with the long axis temporally superior, and the iris demonstrated inferior sectoral atrophy involving 2 clock hours. Posterior segment examination showed a C/D ratio of 0.6 with inferior thinning and peripheral laser scars. The retinal vasculature of the venous tree appeared normal in caliber; however, the retinal arterioles were attenuated and hyalinized ( fig. 2) .
Anterior segment fluorescein angiography demonstrated an absence of vascular flow in the iris, except at the pupillary margin, extensive limbal microaneurysms, partial filling of the saccular dilations and vascular tortuosity.
The inferior nasal cornea demonstrated early neovascularization. Leakage of fluorescein into the anterior chamber was noted after 1 min of fluorescein injection ( fig. 3) .
No changes were demonstrated in the clinical findings over a period of observation of 5 months.
Discussion
Ernst Coccius [3] was the first to observe the circulation in the conjunctival vessels in 1852. The recognition of an association between systemic degenerative vascular disease and the bulbar conjunctival microcirculation lagged behind the knowledge of this association with the retinal circulation by several decades [2, 4] .
We postulate that the conjunctival vascular changes in our case are the result of a combination of three main factors: (1) vascular remodeling secondary to postoperative conjunctival wound healing, (2) degenerative vascular changes secondary to diabetes, and (3) factors related to NVG.
Vascular Remodeling Secondary to Postoperative Conjunctival Wound Healing
The complex and dynamic process of wound healing is divided into three phases: inflammatory, proliferative and remodeling [5] .
Angiogenesis occurs during the proliferative phase, signaled by the interaction of vascular endothelial growth factors (VEGFs) and their receptors. In mature vessels, angiopoietin (Ang1) binding to receptor Tie2 maintains the association of periendothelial support cells. Binding Ang2 to receptor Tie2 loosens the contact between the vascular structures, the extracellular matrix and the perivascular cells, allowing access to angiogenic factors. Other factors such as platelet-derived growth factor and transforming growth factor-β (TGF-β) and their receptors are important for vascular maturation and remodeling [6] .
This dynamic mechanism may have played a significant role in the development of the clinical features seen in our case, evidenced by the absence of similar findings in the contralateral eye that did not undergo a conjunctival peritomy necessary for glaucoma implant surgery.
Degenerative Vascular Changes Secondary to Diabetes
Bulbar conjunctival microvascular changes in type II diabetes include conjunctival edema, hyaline-like infiltration, hemorrhage and intravascular cellular aggregation. Morphologic vascular changes include capillary tortuosity, venous and capillary elongation, localized venous dilation and sacculation. Alterations in the arteriolar:venular ratio range from 1:3 to 1:2 in normal subjects to 1:6 in diabetics [1, 7] , with a reduction in vessel density by 14% and an increase in mean vessel width by 5% [8] .
Factors that modify the clinical picture include the grade of diabetic retinopathy, which is positively correlated with the severity of conjunctival microangiopathy [9] and the duration of diabetes, which is associated with both an overall reduction in tortuosity in macrovessels and an increased tortuosity in capillary-sized vessels [4] .
The multistep process of angiogenesis is tightly controlled by a dynamic balance between positive and negative regulators. Positive regulators of angiogenesis include VEGF-A, fibroblast growth factor, angiopoietins, TGF-α and TGF-β, hepatocyte growth factor, connective tissue growth factor and interleukin-8. There is considerable evidence that VEGF-A is a prime regulator of angiogenesis. VEGF-A stimulates endothelial cells to degrade their basement membrane and to migrate with the concomitant release of matrix metalloproteinases and plasminogen activators and the expression of αVβ3 and αVβ5 integrins. Furthermore, VEGF-A is able to stimulate endothelial cells to proliferate, form tubes in vitro and survive [10] .
Delayed onset of the conjunctival findings may be explained through diabetes-induced endothelial cell dysfunction, causing dysregulation of angiogenic factors and subsequent aberrant angiogenic responses, primarily through the increased production of reactive oxy-gen species via the activity of enzymes, such as nicotinamide adenine dinucleotide phosphate oxidase, aldehyde oxidase, xanthine oxidase and glucose oxidase, and in addition to mitochondrial uncoupling [11] .
Our findings are consistent with descriptions of other investigators. The clinically evident severity of retinopathy and the duration of diabetes would have influenced the nature, delayed onset and progression of the clinical pattern.
Factors Related to NVG
NVG is a risk factor for conjunctival melt and glaucoma implant exposure (odds ratio 28.5), which suggests preexisting conjunctival microcirculatory abnormalities in this group of patients [12] . The lack of vascular flow in the iris as indicated by fluorescein angiography indicates a severe degree of ocular ischemia [13] . In addition, NVG increases the levels of VEFG and placental growth factor in the aqueous humor [14] .
In our case, the patient's history of NVG, ongoing ocular ischemia and the influences of angiogenic factors in the aqueous humor, and even the absence of active proliferative changes, may have influenced the conjunctival vascular changes.
Conclusion
We hypothesize that the clinical features in our case may have been modified by a combination of postoperative wound healing and degenerative vascular remodeling, in addition to microvascular alterations secondary to both diabetes and consequent ocular ischemia, which may have played a role.
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